Asia-Pacific Interventional Cardiology Market Research Report- Forecast To 2027

Interventional Cardiology Market Research Report, By Types (Catheters, Stents, Balloons, Vascular Closure Devices, Laser Procedures, Atherectomy And Other), By End Users (Catheterization Laboratories, Hospitals And Clinics And Others) –Asia Pacific Forecast Till 2027

ID: MRFR/MED/0682-HCR | February 2021 | Region: Global | 80 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Study objectives Asia Pacific interventional cardiology market



  • Detailed information about the factors affecting the growth of the Asia Pacific interventional cardiology

  • Detailed analysis of parent market with respect to all the possible segmentation of the market.

  • Detailed analysis of emerging key players for the market with their effective strategies.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Asia Pacific interventional cardiology market.

  • Analysis of the market of the different factors like- Price Analysis, Supply Chain Analysis, Porters’ Five Force Analysis etc.

  • Detailed information on the possible segments and sub segments of the market and its regional analysis.

  • Insights on the major countries in which this industry is blooming and to also identify the regions that are still untapped

  • Detailed information on trends and the opportunities in various regions


Intended Audience



  • Research and Development (R&D) Companies

  • Catheter manufacturing company



  • Government and Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Asia Pacific interventional cardiology market, by application


 Asia Pacific interventional cardiology market


Sources- Annual reports, White paper, Company Presentation


Market Scenario:


Interventional cardiology is a branch of cardiology that deals with catheter based treatment for heart diseases. By catheterization, number of procedures can be performed on the heart. According to International Diabetes Federation, 60% of world’s total diabetic population lives in Asia. Diabetic is one of the major factors which lead to cardiovascular diseases. Increasing prevalence of cardiovascular diseases is the major factor for the growth of the market in Asia Pacific. Beside this increasing incidences of diabetes and obesity, change in lifestyle, increasing awareness among the people and rapid development in technology also contributed to the growth of the market. On other hand, high cost for manufacturing the devices and lot of barriers for the development of the new device are the major restraints hampering the market growth.


Asia Pacific interventional cardiology market is expected to grow at a CAGR of 7.9% during the forecasted period 2017-2023.


Market Assessment


 Asia Pacific interventional cardiology Market Assessment


Sources- Annual reports, World Health Organization (WHO), White paper, Company Presentation, International Diabetes Federation


Segmentation


Asia Pacific interventional cardiology market is segmented on the basis of type, into catheters, stents, balloons, vascular closure devices, laser procedures, atherectomy and other. Stents are sub segmented into metal stents, drug eluting stents and bioresorbable stents. Balloons are further segmented into cutting balloons, drug eluting balloons and other. On the basis of end users the market is segmented into catheterization laboratories, hospitals and clinics and others


Regional Analysis:


On the basis of region, Asia Pacific market for interventional cardiology is segmented into countries namely Japan, India, China, Australia, Republic of Korea and Rest of Asia Pacific. China accounts for the largest market share which is attributed to an increase in incidence of chronic heart diseases, increasing geriatric population, and demand for early diagnosis of cardiac disease. India holds the second largest market whereas Japan shows steady growth in this market.


Key Players for Asia Pacific interventional cardiology market


Abbott Laboratories Inc. (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Abiomed Inc. (U.S), Edwards Lifesciences (U.S.), Biosensors International Group, Ltd. ( Singapore), Boston Scientific Corporation (U.S.), Medtronic PLC (Ireland), Angiodynamics, Inc. ( U.S), Terumo Medical Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.)., Lombard Medical Technologies, Plc. (U.K), Clearstream Technologies Group Plc. (Ireland).


The report for Asia Pacific interventional cardiology market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



TABLE OF CONTENTS




1 INTRODUCTION


1.1 DEFINITION


1.2 SCOPE OF STUDY


1.2.1 RESEARCH OBJECTIVE


1.2.2 ASSUMPTIONS & LIMITATIONS


1.2.2.1 ASSUMPTIONS


1.2.2.2 LIMITATIONS


1.3 MARKET STRUCTURE:


2 RESEARCH METHODOLOGY


2.1 RESEARCH PROCESS:


2.2 PRIMARY RESEARCH


2.3 SECONDARY RESEARCH:


3 MARKET DYNAMICS


3.1 DRIVERS


3.2 RESTRAINTS


3.3 OPPORTUNITIES


3.4 MACROECONOMIC INDICATORS


4 MARKET FACTOR ANALYSIS


4.1 PORTERS FIVE FORCES MODEL


4.2 BARGAINING POWER OF SUPPLIERS


4.3 BARGAINING POWER OF BUYERS


4.4 THREAT OF NEW ENTRANTS


4.5 THREAT OF SUBSTITUTES


4.6 INTENSITY OF RIVALRY


ASIA PACIFIC INTERVENTIONAL CARDIOLOGY MARKET, BY TYPE

5.1 CATHETERS


5.2 STENTS


5.2.1 METAL STENTS


5.2.2 DRUG ELUTING STENTS


5.2.3 BIORESORBABLE STENTS


5.3 BALLOONS


5.3.1 CUTTING BALLOONS


5.3.2 DRUG ELUTING BALLOONS


5.3.3 OTHER


5.4 VASCULAR CLOSURE DEVICES


5.5 LASER PROCEDURES


5.6 ATHERECTOMY


5.7 OTHER


ASIA PACIFIC INTERVENTIONAL CARDIOLOGY MARKET, BY END USER

6.1 CATHETERIZATION LABORATORIES


6.2 HOSPITALS AND CLINICS


6.3 OTHER


ASIA PACIFIC INTERVENTIONAL CARDIOLOGY MARKET, BY REGION

7.1 INTRODUCTION


7.2 ASIA-PACIFIC


7.2.1 JAPAN


7.2.2 CHINA


7.2.3 INDIA


7.2.4 AUSTRALIA


7.2.5 REPUBLIC OF KOREA


7.2.6 REST OF ASIA-PACIFIC


COMPETITIVE LANDSCAPE

8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS


8.1.1 STRATEGIC PARTNERSHIP


8.1.2 MERGER & ACQUISITION


9 COMPANY PROFILE


9.1 ABBOTT LABORATORIES INC


9.1.1 OVERVIEW


9.1.2 PRODUCT OVERVIEW


9.1.3 FINANCIALS


9.1.4 KEY DEVELOPMENTS


9.2 BOSTON SCIENTIFIC CORPORATION


9.2.1 OVERVIEW


9.2.2 PRODUCT OVERVIEW


9.2.3 FINANCIALS


9.2.4 KEY DEVELOPMENTS


9.3 MEDTRONIC PLC


9.3.1 OVERVIEW


9.3.2 PRODUCT OVERVIEW


9.3.3 FINANCIALS


9.3.4 KEY DEVELOPMENT


9.4 B. BRAUN MELSUNGEN AG


9.4.1 OVERVIEW


9.4.2 PRODUCT OVERVIEW


9.4.3 FINANCIALS


9.4.4 KEY DEVELOPMENTS


9.5 BIOSENSORS INTERNATIONAL GROUP, LTD


9.5.1 OVERVIEW


9.5.2 PRODUCT OVERVIEW


9.5.3 FINANCIALS


9.5.4 KEY DEVELOPMENTS


9.6 JOHNSON & JOHNSON SERVICES, INC.


9.6.1 OVERVIEW


9.6.2 PRODUCT OVERVIEW


9.6.3 FINANCIALS


9.6.4 KEY DEVELOPMENTS


9.7 LOMBARD MEDICAL TECHNOLOGIES, PLC


9.7.1 OVERVIEW


9.7.2 PRODUCT OVERVIEW


9.7.3 FINANCIALS


9.7.4 KEY DEVELOPMENTS


9.8 TERUMO MEDICAL CORPORATION


9.8.1 OVERVIEW


9.8.2 PRODUCT OVERVIEW


9.8.3 FINANCIALS


9.8.4 KEY DEVELOPMENTS


9.9 OTHERS


10 CONCLUSION


10.1 KEY FINDINGS


10.1.1 FROM CEO’S VIEWPOINT


10.1.2 UNMET NEEDS OF THE MARKET


10.2 KEY COMPANIES TO WATCH


10.3 PREDICTION OF CARDIOVASCULAR DEVICES INDUSTRY


11 APPENDIX




LIST OF TABLES




Table 1 Interventional Cardiology Industry Synopsis, 2020-2027


Table 2 Asia Pacific Interventional Cardiology Market Estimates & Forecast, 2020-2027, (USD Million)


Table 3 Asia Pacific Interventional Cardiology Market, by Region, 2020-2027, (USD Million)


Table 4 Asia Pacific Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 5 Asia Pacific Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 Japan Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 Japan Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 China Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 China Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 India Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 India Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 Australia Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 Australia Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 Republic of Korea Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 Republic of Korea Interventional Cardiology Market, by End-User, 2020-2027, (USD Million)


Table 20 Rest of Asia Pacific Interventional Cardiology Market, by Type, 2020-2027, (USD Million)


Table 21 Rest of Asia Pacific Interventional Cardiology Market, by End-User, 2020-2027, (USD Million) 




LIST OF FIGURES




Figure 1 Research Process


Figure 2 Segmentation for Asia Pacific Interventional Cardiology Market


Figure 3 Segmentation Market Dynamics for Interventional Cardiology Market


Figure 4 Asia Pacific Interventional Cardiology Market Share, by Type 2020


Figure 5 Asia Pacific Interventional Cardiology Market Share, by End Users, 2020


Figure 6 Asia Pacific Interventional Cardiology Market Share, by Country, 2020


Figure 7 Asia Pacific Interventional Cardiology Market: Company Share Analysis, 2020 (%)